Skip to content

The COVID-19 pandemic disrupted HIV prevention and care in Barcelona, but new cases and viral loads didn’t increase

Laia Ros Padulles/Shutterstock.com. Image is for illustrative purposes only.

South London clinics find the people lost to HIV care – and tell some of their stories

Dr Kate Childs at BHIVA 2022. Image by Roger Pebody.

Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV

Jarun Otakrai-Shutterstock/Pexels

A quarter of 2020 deaths of people with HIV in the UK due to COVID-19

Dr Sara Croxford at BHIVA 2022. Image by Roger Pebody.

Nearly one in five people with HIV in the UK could have a detectable viral load

Dr Alison Brown at BHIVA 2022. Image by Roger Pebody.

Four in ten PrEP recipients stop taking it within six months, global meta-analysis reveals

Bowonpat Sakaew/Shutterstock.com

Can HIV cure trials strike a balance between the need for meaningful data and participant safety?

Elle Aon/Shutterstock.com

UK report urges re-think on hepatitis C reinfection

Needle exchange/naloxone supply in Birmingham. Nigel Brunsdon/nigelbrunsdon.com

Preferences or circumstances? What makes gay and bisexual men in Australia choose not to take PrEP?

Image by Doctor 4U. Creative Commons licence.